Prestige Consumer Healthcare Inc.
Prestige Consumer Healthcare Inc. (PBH) Stock Competitors & Peer Comparison
See (PBH) competitors and their performances in Stock Market.
Peer Comparison Table: Medical - Distribution Industry
Detailed financial metrics including price, market cap, P/E ratio, and more.
Symbol | Price | Change % | Market Cap | P/E Ratio | EPS | Dividend Yield |
---|---|---|---|---|---|---|
PBH | $74.65 | -2.16% | 3.7B | 17.40 | $4.29 | N/A |
MCK | $712.15 | +0.83% | 88.9B | 27.71 | $25.70 | +0.40% |
COR | $289.77 | +1.25% | 56.2B | 33.50 | $8.65 | +0.75% |
CAH | $157.39 | +0.68% | 37.6B | 24.59 | $6.40 | +1.29% |
ABC | $179.98 | -0.23% | 36.1B | 21.92 | $8.21 | N/A |
HSIC | $70.05 | -0.58% | 8.5B | 21.82 | $3.21 | N/A |
PDCO | $31.33 | +0.00% | 2.8B | 20.48 | $1.53 | +0.83% |
GRDN | $20.33 | -1.98% | 1.3B | -12.79 | -$1.59 | N/A |
OMI | $7.45 | -5.34% | 571.2M | -1.57 | -$4.76 | N/A |
ZYXI | $2.48 | -3.13% | 75M | -10.33 | -$0.24 | N/A |
Stock Comparison
PBH vs MCK Comparison July 2025
PBH plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PBH stands at 3.7B. In comparison, MCK has a market cap of 88.9B. Regarding current trading prices, PBH is priced at $74.65, while MCK trades at $712.15.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PBH currently has a P/E ratio of 17.40, whereas MCK's P/E ratio is 27.71. In terms of profitability, PBH's ROE is +0.12%, compared to MCK's ROE of -1.33%. Regarding short-term risk, PBH is more volatile compared to MCK. This indicates potentially higher risk in terms of short-term price fluctuations for PBH.Check MCK's competition here